Clinical Trials and Therapeutic Approaches for Healthcare Challenges in Pakistan

Pakistan faces tremendous challenges in providing healthcare due to a lack of consistent policymaking, increasing expenditure and exponential growth in population since its inception in 1947. These challenges are not just driven by politics, policy and allocation of resources but also by healthcare, environment and characteristics of the population biology. Clinical trials provide the best way to find population-specific, cost-effective treatments that do not merely mimic those used in wealthier nations. This article analyzes all clinical studies conducted with at least one site in Pakistan listed on ClinicalTrials.gov, combined with a short overview that considers new therapeutic approaches that can be investigated in future clinical trials. Therapies using repurposed medicines are of particular interest as they use affordable drugs that are already widely available.

Automated summary

Pakistan faces significant challenges in providing healthcare due to inconsistent policymaking, rising expenditure, and population growth. Clinical trials are crucial for finding population-specific, cost-effective treatments. Repurposing medicines offers a particularly promising approach as it utilizes affordable drugs that are already widely available.